Latest Health News

3Aug
2023

Marijuana Use by Youth: After Legalization, Education Seems to Matter

Marijuana Use by Youth: After Legalization, Education Seems to MatterTHURSDAY, Aug. 3, 2023 (HealthDay News) -- After their U.S. states legalize marijuana, young adults who aren't in college are more likely than college kids to use the drug and progress to cannabis use disorder, a new study finds.Prior to legalization, 23% of non-college young adults reported using cannabis in the past month, and after legalization it went up to 28%, researchers found. Among U.S. college students in the same age bracket, use only increased by 1 percentage point after legalization, from 20% to 21%.“Researchers should continue to monitor changes in prevalence of cannabis use, frequent cannabis use and cannabis use disorder among young adults while the cannabis landscape in the U.S. continues to evolve,” said study co-author Dr. Silvia Martins, a professor of...

Bullying Could Help Bring on Headaches for Teens

3 August 2023
Bullying Could Help Bring on Headaches for TeensTHURSDAY, Aug. 3, 2023 (HealthDay News) -- So, your high schooler has been complaining of headaches. Should you worry?Maybe, claims new research that finds bullying and suicidal thoughts are both linked to more frequent headaches in teens.“Headaches are a common problem for teenagers, but our study looked beyond the biological factors to also consider the psychological and social factors that are associated with headaches,” said study author Dr. Serena Orr, of the University of Calgary, in Canada. “Our findings suggest that bullying and attempting or considering suicide may be linked to frequent headaches in teenagers, independent of mood and anxiety disorders.”This isn’t proof that bullying causes headaches, but shows an association between the two. A study limitation is...

Dr. Jeanne Marrazzo Will Replace Fauci to Lead National...

2 August 2023
Dr. Jeanne Marrazzo Will Replace Fauci to Lead National Institute of Allergy and Infectious DiseasesWEDNESDAY, Aug. 2, 2023 (HealthDay News) -- Dr. Jeanne Marrazzo was named on Wednesday to become the next head of the U.S. National Institute of Allergy and Infectious Diseases, a job most recently held by Dr. Anthony Fauci, well known for his work on HIV and the pandemic. Marrazzo will start her new job in the fall. She is currently the director of the Division of Infectious Diseases at the University of Alabama at Birmingham.“Dr. Marrazzo brings a wealth of leadership experience from leading international clinical trials and translational research, managing a complex organizational budget that includes research funding and mentoring trainees in all stages of professional development,” Dr. Lawrence Tabak, acting director for the U.S. National Institutes of Health (NIH), said in an...

AHA News: Mom of 2 Survived Heart Failure During...

2 August 2023
AHA News: Mom of 2 Survived Heart Failure During Pregnancy and Became Certified ParamedicWEDNESDAY, Aug. 2, 2023 (American Heart Association News) -- Since she was a child, Yanela Vickers has loved babies and the medical field. She dreamed of going into obstetrics and gynecology.Instead, Yanela got a close look at the profession as a patient. She was 18 and five months pregnant when she walked across the stage to collect her high school diploma in June 2007.For the past two months, Yanela had felt so fatigued she could hardly get out of bed. Still, she dragged herself to class.Her abdomen grew at a rate that seemed abnormal and was often painful. Her legs were swollen. She developed high blood pressure and frequently had shortness of breath.She was seeing her doctor regularly but felt dismissed because she was young and Hispanic. Whenever problems seemed alarming, her...

Gene Could Lower HIV Levels in Some People of African Descent

2 August 2023
Gene Could Lower HIV Levels in Some People of African DescentWEDNESDAY, Aug. 2, 2023 (HealthDay News) -- A newly discovered genetic variant might explain why some people of African ancestry have naturally lower viral loads of HIV, an international team of researchers reports.This variant, carried by an estimated 4% to 13% of people of African origin, reduces their risk of transmitting the virus and slows the progress of their own illness.It’s the first new genetic variant related to HIV infection discovered in nearly 30 years of research, according to the report, published Aug. 2 in the journal Nature.This discovery could boost development of new treatments for people living with HIV, said co-lead researcher Harriet Groom, an infectious disease research fellow with the University of Cambridge's department of medicine, in the United...

Millions of Smokers May Have a Tough-to-Diagnose Lung Disease

2 August 2023
Millions of Smokers May Have a Tough-to-Diagnose Lung DiseaseWEDNESDAY, Aug. 2, 2023 (HealthDay News) -- Millions of American smokers suffer from a potentially serious lung disease that's not technically chronic obstructive pulmonary disease (COPD), a new study finds. They would benefit from a clear diagnosis, though, and the new findings demonstrate a major gap in care for people with a history of tobacco use, the researchers said. Among folks who smoked at least one pack of cigarettes a day for 20 or more years, half had persistently high respiratory symptoms, including shortness of breath, daily cough and phlegm, and decreased ability to exercise, although they did well in the breathing tests used to spot COPD. The researchers call the condition "tobacco exposure preserved spirometry" (TEPS)."We first described TEPS in 2016. What we're...

Pill to Counter Postpartum Depression Looks Good in Trial, May Gain FDA Approval

2 August 2023
Pill to Counter Postpartum Depression Looks Good in Trial, May Gain FDA ApprovalWEDNESDAY, Aug. 2, 2023 (HealthDay News) -- All eyes are on the U.S. Food and Drug Administration this week as the agency weighs approval of a new pill that may quickly treat and ease severe postpartum depression. Approval of the drug could help millions of women regain their emotional equilibrium following childbirth. The FDA's decision is expected by Friday.Taken as a pill once a day for two weeks, zuranolone showed “rapid, significant and sustained” reductions in depressive symptoms when compared to a placebo, or dummy pill, according to a recent study of nearly 200 women.These improvements occurred in as few as three days and were still evident 28 and 45 days later, said study author Dr. Kristina Deligiannidis. She is a professor at the Institute of Behavioral Science at the...

Long Targeted in Abortion Battle, U.S. Global AIDS Program Gets New Home in State Department

2 August 2023
Long Targeted in Abortion Battle, U.S. Global AIDS Program Gets New Home in State DepartmentWEDNESDAY, Aug. 2, 2023 (HealthDay News) -- The President’s Emergency Program for AIDS Relief (PEPFAR), a program that's long successfully provided relief to people with AIDS around the world, will now be housed within the U.S. State Department. The move comes after years of pressure by anti-abortion groups and some Republican members of Congress to attach abortion-related limits on U.S. health support overseas, including PEPFAR. The program was started by President George W. Bush in 2003, and has received about $100 billion in U.S. funding over the past two decades. But PEPFAR will now be included within the new Bureau of Global Health Security and Diplomacy, part of the State Department, the Associated Press reported.The newly created bureau is meant to make health security a...

Could Exposure to Lead Early in Life Raise Odds for...

WEDNESDAY, Aug. 2, 2023 (HealthDay News) -- Being exposed to lead while in the womb or during early childhood may increase a person’s chance of engaging in criminal behavior as an adult, a new...

Surgery May Help Advanced Cancer Patients With...

THURSDAY, Aug. 3, 2023 (HealthDay News) -- Malignant bowel blockages are common in patients who have advanced abdominal tumors, especially cancers of the ovaries or colon, and a new clinical trial...
RSS
First5152535456585960Last